A Comprehensive Analysis of Sex-Biased Gene Expression in the Aging Human Retina Through a Combination of Single-Cell and Bulk RNA Sequencing
Investigative Ophthalmology & Visual Science · 2025
DOI: 10.1167/iovs.66.1.28 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, 2025. Written by Hongling Liu and 5 co-authors. Institution: Southwest Hospital/Southwest Eye Hospital, Third Military Medical University (Army Medical University), Chongqing, China. Major MEDLINE topics: Aging, Retina, Gene Expression Regulation. Cited 13 times so far (Crossref); 54 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Purpose
Previous studies have reported divergent sexual responses to aging; however, specific variations in gene expression between aging males and females and their potential association with age-related retinal diseases remain unclear. This study collected data from public databases and developed a comprehensive comparison of retina between aging females and males.
Methods
Single-cell RNA (scRNA) and bulk RNA sequencing data of the aging retina from females and males in public databases were utilized for integrated analysis to investigate sex-biased expression in retina. Additionally, in vitro experiments were conducted on individuals with retinitis pigmentosa (RP) to validate the sex difference in degenerative retina.
Results
Bulk RNA analysis revealed sex-biased expression of specific genes in retina of aging individuals, with immune pathway-related genes exhibiting higher expression in females compared to males. The scRNA analysis demonstrated that sex-biased gene expression was cell-type specific in aging retina. Furthermore, susceptibility genes for age-related macular degeneration and RP exhibited variation across different cell types and sexes. Cell-to-cell communication unveiled an increased interaction associated with TGFB1, CCL7, and VEGFA in Müller glia, microglia, and astrocytes of female retina. Notably, we observed female-biased chemokine expression in microglia contributing to heightened susceptibility to immune inflammation in female retina. Finally, we confirmed a more pronounced inflammatory response during degeneration in female rd10 mouse retina compared to males.
Conclusions
This study provides a comprehensive comparison of retina between females and males in healthy aging human retina and highlights the significance of sex as an influential factor in retinal diseases.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Southwest Hospital/Southwest Eye Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
- Key Lab of Visual Damage and Regeneration & Restoration of Chongqing, Chongqing, China.
- Jinfeng Laboratory, Chongqing, China.
- Army 953 Hospital, Shigatse Branch of Xinqiao Hospital, Third Military Medical University (Army Medical University), Shigatse, China.
- State Key Laboratory of Trauma, Burns, and Combined Injury, Department of Trauma Medical Center, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Cite
APA
Liu, H., Zhang, X., Wang, Q., Li, B., Bian, B., & Liu, Y. (2025). A Comprehensive Analysis of Sex-Biased Gene Expression in the Aging Human Retina Through a Combination of Single-Cell and Bulk RNA Sequencing. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.1.28
Vancouver
Liu H, Zhang X, Wang Q, Li B, Bian B, Liu Y. A Comprehensive Analysis of Sex-Biased Gene Expression in the Aging Human Retina Through a Combination of Single-Cell and Bulk RNA Sequencing. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.1.28
BibTeX
@article{Liu2025,
author = {Liu, Hongling and Zhang, Xue and Wang, Qing and Li, Bowen and Bian, Baishijiao and Liu, Yong},
title = {A Comprehensive Analysis of Sex-Biased Gene Expression in the Aging Human Retina Through a Combination of Single-Cell and Bulk RNA Sequencing},
journal = {Investigative Ophthalmology & Visual Science},
year = {2025},
doi = {10.1167/iovs.66.1.28}
}
EUVIMED